What is it about?
Urine samples from patients with adrenal tumors were analyzed by untargeted metabolomics. We identified several steroid conjugates as potential novel biomarkers for adrenocortical carcinoma and highlight limitations of enzymatic steroid hydrolysis.
Featured Image
Read the Original
This page is a summary of: An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors, Clinical Chemistry and Laboratory Medicine (CCLM), January 2025, De Gruyter,
DOI: 10.1515/cclm-2024-1337.
You can read the full text:
Contributors
Be the first to contribute to this page
